"Therapeutics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Procedures concerned with the remedial treatment or prevention of diseases.
Descriptor ID |
D013812
|
MeSH Number(s) |
E02
|
Concept/Terms |
Therapeutics- Therapeutics
- Therapeutic
- Therapy
- Therapies
- Treatment
- Treatments
|
Below are MeSH descriptors whose meaning is more general than "Therapeutics".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Therapeutics [E02]
Below are MeSH descriptors whose meaning is more specific than "Therapeutics".
This graph shows the total number of publications written about "Therapeutics" by people in this website by year, and whether "Therapeutics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2003 | 2 | 0 | 2 |
2004 | 1 | 0 | 1 |
2005 | 2 | 0 | 2 |
2006 | 1 | 0 | 1 |
2007 | 2 | 0 | 2 |
2009 | 0 | 1 | 1 |
2011 | 1 | 0 | 1 |
2013 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2017 | 0 | 1 | 1 |
2018 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Therapeutics" by people in Profiles.
-
Resuscitative endovascular balloon occlusion of the aorta for non-traumatic intra-abdominal hemorrhage. Eur J Trauma Emerg Surg. 2019 Aug; 45(4):713-718.
-
A multi-source adaptive platform design for testing sequential combinatorial therapeutic strategies. Biometrics. 2018 09; 74(3):1082-1094.
-
Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial. J Clin Oncol. 2017 Oct 10; 35(29):3315-3321.
-
Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases. Am J Surg Pathol. 2016 May; 40(5):676-88.
-
Denosumab for treatment of hypercalcemia of malignancy. J Clin Endocrinol Metab. 2014 Sep; 99(9):3144-52.
-
Full disclosure--out-of-pocket costs as side effects. N Engl J Med. 2013 Oct 17; 369(16):1484-6.
-
Toward an integrated knowledge environment to support modern oncology. Cancer J. 2011 Jul-Aug; 17(4):257-63.
-
The first silicone breast implant patient: a 47-year follow-up. Plast Reconstr Surg. 2010 Jun; 125(6):226e-229e.
-
RNA and disease. Cell. 2009 Feb 20; 136(4):777-93.
-
Costs of adverse events in intensive care units. Crit Care Med. 2007 Nov; 35(11):2479-83.